Frederick, Maryland – November 20, 2024 – OMAPiX, a leader in spatial multiomics custom data and analytics solutions, today announced a strategic partnership with Parse Biosciences, a pioneer in scalable single-cell sequencing technology. Through this collaboration, OMAPiX is now a Certified Service Provider (CSP) offering Parse Biosciences’ innovative single-cell sequencing products, which utilize a proprietary fixation and permeabilization method, combined with combinatorial barcoding, to generate high throughput and high-quality single-cell datasets.
OMAPiX offers a diverse portfolio of platforms, including high-throughput in situ sequencing, single-cell and spatial transcriptomics, spatial profiling, and image analysis. These solutions are designed to help pharmaceutical, academic, and biotechnology research organizations gain a deeper understanding of cellular function and disease mechanisms.
“While traditionally seen as a spatial biology lab, the new OMAPiX is designed to support an array of research approaches. Our passion, to bring precision medicine to patients, can only truly propel forward if we enable access to the advances the OMICs field has seen in recent years. As such, it has been exciting to bring in new product offerings, such as Parse Biosciences, to support a range of applications,” said Linda Orzolek, the new head of lab operations at OMAPiX.
The company’s newly expanded, state-of-the-art laboratory in Frederick, MD, is equipped with cutting-edge technologies to analyze the genome, transcriptome and proteome at unmatched resolution, opening the doors for both novel discoveries and clinical validations.
OMAPiX’s deep expertise in spatial biology and molecular profiling enables the company to provide tailored solutions for clients across various stages of drug discovery and development. The company is rapidly scaling its capabilities in both sample processing and data analytics to meet the growing demand for spatial and multiomics solutions.
“We are thrilled to partner with OMAPiX and add them to our network of certified service providers,” said Alex Rosenberg, CEO and co-founder of Parse Biosciences.” Their expertise and commitment to excellence make them an invaluable partner in providing the research community with scalable and high-quality single-cell solutions.”
This partnership strengthens OMAPiX’s position as a comprehensive solution for research and clinical applications, covering gene expression analysis, protein localization, cell interactions, and tissue-level profiling.
As a CSP, OMAPiX’s expertise in single-cell library preparation enables more researchers to delve into large-scale studies. “I have been running single-cell assays since Parse was still known as SPLiT-seq,” said Ms. Orzolek. “I trust the product that Parse offers, and I trust our lab’s ability to run it effectively. Single-cell projects can be costly and time-consuming and an overwhelming task for some labs. I love that we can encourage more labs to confidently take these steps forward in their research, knowing that they can rely on the expertise and skill of Parse and OMAPiX as a team.”
To learn more about OMAPiX’s deep molecular profiling services, visit www.OMAPiX.com.
